Skip to main content
Veterinary Medicines

Nobivac Respira Bb vet. suspension for injection for dogs

Authorised
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae

Product identification

Medicine name:
Nobivac Respira Bb vet. suspension for injection for dogs
Nobivac Respira Bb
Active substance:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
    88.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB03
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.12016.01.1
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0123/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/03/2023

PI.pdf

English (PDF)
Published on: 27/01/2022
Download